Editorial on Inflammatory Breast Cancer1
“Why and What” for the optimal management of inflammatory breast cancer
Chinese Clinical Oncology
2021;
10
(6)
:54
.
(31 December 2021)
Review Article on Inflammatory Breast Cancer1
What is the best systemic treatment for newly diagnosed inflammatory breast cancer?—a narrative review
Chinese Clinical Oncology
2021;
10
(6)
:55
.
(31 December 2021)
Baseline FDG PET-CT imaging is necessary for newly diagnosed inflammatory breast cancer patients: a narrative review
Chinese Clinical Oncology
2021;
10
(6)
:56
.
(31 December 2021)
Contemporary surgical management of inflammatory breast cancer: a narrative review
Chinese Clinical Oncology
2021;
10
(6)
:57
.
(31 December 2021)
Why diagnosing inflammatory breast cancer is hard and how to overcome the challenges: a narrative review
Chinese Clinical Oncology
2021;
10
(6)
:58
.
(31 December 2021)
What is the best treatment recommendation for HER2+ IBC with residual disease?—a narrative review
Chinese Clinical Oncology
2021;
10
(6)
:59
.
(31 December 2021)
How should radiation be done for inflammatory breast cancer patients?—a narrative review of modern literature
Chinese Clinical Oncology
2021;
10
(6)
:60
.
(31 December 2021)
Disclosure:
1. The series “Inflammatory Breast Cancer” was commissioned by the Editorial office, Chinese Clinical Oncology without any sponsorship or funding. Professor Naoto T. Ueno served as the unpaid Guest Editor for the series.
